Makoto Sakamoto
8PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 11, 2026
Correction: Bevacizumab enhances overall survival in newly diagnosed glioblastoma patients with high COX-2 expression.Irfan Kesumayadi, Atsushi Kambe, Haruto Kanda
|Feb 05, 2026
Efficacy and safety profiles of single versus multiple pipeline embolization devices for intracranial aneurysms: a systematic review and meta-analysis.Irfan Kesumayadi, Makoto Sakamoto, Hidefumi Amisaki
|Feb 01, 2026
Drug-induced hypertension is associated with improved survival in glioblastoma patients treated with bevacizumab: evidence from a time-to-event meta-analysis and meta-regression.Irfan Kesumayadi, Atsushi Kambe, Hidefumi Amisaki
|Jan 10, 2026
Bevacizumab enhances overall survival in newly diagnosed glioblastoma patients with high COX-2 expression.Irfan Kesumayadi, Atsushi Kambe, Haruto Kanda
|Sep 09, 2025
Prognostic value of hypertension timing for survival in glioblastoma patients receiving bevacizumab: a retrospective single centre analysis.Irfan Kesumayadi, Atsushi Kambe, Hidefumi Amisaki
|Jun 04, 2025
Low-Grade Primary Intramedullary Spinal Cord Astroblastoma: A Case Report and Literature Review.Irfan Kesumayadi, Atsushi Kambe, Tetsuji Uno
Pageof 2
